Search

Fluorescence in situ hybridization showed that up to 19% of SAR11 (Pelagibacterales) cells were phage-infected during a phytoplankton bloom, coinciding with a roughly 90% drop in SAR11 abundance within 5 days. A fraction of infected cells h

In a recent study, researchers discovered that broad host range phages have the potential to effectively target and clear global Clostridium perfringens bacterial strains in poultry, offering an alternative treatment option for infections,

The International Society of Viruses of Microorganisms (ISVM) is inviting enthusiastic and dedicated members to apply to become organizers of the Viruses of Microbes 2026 conference by 30 April 2024, with the selected organizers to be annou

Registration is now open for the 2024 International Soil Virus Conference! Soil virologists and enthusiasts will gather to explore the multifaceted roles of soil viruses within a One Health framework, with a special focus on meta-omics cha

Actiphage TB, a novel phage-based TB diagnostic developed by PBD Biotech, has been recognized as a semi-finalist in the ADLM 2024 Disruptive Technology Awards.

Michael Koeris (who has founded multiple phage companies, and is one of Capsid & Tail’s earliest/longest-standing supporters) has been appointed as the new Office Director of the Biological Technologies Office at DARPA, where he will priori

The Leo Foundation has granted 4 million DKK to a new innovative phage therapy project led by Thomas Sicheritz-Pontén (University of Copenhagen), aiming to combat necrotizing soft tissue infections by harnessing Group A Strep-targeting phag

Swiss startup NEMIS Technologies AG will focus on the use of phage technology for food safety, starting with Listeria.

Samuel Greenrod (University of Oxford) and colleagues explored the effects of warming on the interaction between the P. aeruginosa and three diverse lytic phages. They found that while temperatures up to 40°C had minimal impact, 42°C signif

Hiba Baaziz (Virginia Tech) and colleagues showed that subtle changes in the lysis-lysogeny decision of Salmonella phage P22 can dramatically impact the emergence of phage resistance.

Phage Canada, a newly established non-profit organization aiming to support and advance phage research and phage therapeutics in Canada, has a new website and is open for membership!

Researchers: want to help develop a phage-based TB diagnostic? Consider sharing samples from previous studies with the team at PDB Biotech. Dr. Timothy Rodwell’s lab at UCSD has already donated over 2,000 frozen PBMC samples for this work,

Nicole Schmid (University of Giessen) and colleagues have described the interactions between a Shewanella inovirus and an autonomously replicating plasmid, which hijacks the phage infection process to preferentially package itself.

Jie-Liang Liang (South China Normal University) and colleagues published a new paper on diversity and ecological function of phosphorus acquisition genes in phages. Their work points to an underestimated role of phages in biogeochemical pho

Carlos Martinez-Soto (Guelph Research and Development Centre, Canada) and colleagues have developed and thoroughly described a new multireceptor phage cocktail against Salmonella enterica to circumvent phage resistance. The cocktail targets

Wei Liu and (Tsinghua University) and colleagues have shown that phage communities contribute to antibiotic resistance genes in sludge plants.

James Bull (University of Idaho) and colleagues published a new paper exploring how best to control phage recombination when mathematically modelling co-infection.

Baylor College of Medicine researchers Anthony Maresso and Michael Tisza, have won the 2024 STAT Madness competition for their groundbreaking work on using wastewater monitoring as an early-warning system for disease outbreaks, demonstratin

Wilfried Moreira is serving as Guest Editor for a new Special Issue on "Bacteriophage Biology and Phage-Derived Technologies" in the open access journal International Journal of Molecular Sciences, with a submission deadline of August 31, 2

Big news! After years in the making, the European Pharmacopoeia Commission has adopted a new general chapter on ‘phage therapy medicinal products’, providing a framework of requirements for their production and control, in an effort to stan